Fiona K. Middleton

Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora et al. · Molecular Oncology · 2014 · 84 citations · Full text

Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition

Fiona K. Middleton, Miranda Patterson, Claire Elstob et al. · Oncotarget · 2015 · 73 citations · Full text

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer

Nouf H. Alsubhi, Fiona K. Middleton, Tarek M.A. Abdel-Fatah et al. · Molecular Oncology · 2015 · 39 citations · Full text

The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation

Fiona K. Middleton, John R. Pollard, Nicola J. Curtin · Cancers · 2018 · 34 citations · Full text

P53 Status, P53 Dysfunction, Cell Death +18

Development of pharmacodynamic biomarkers for ATR inhibitors

Tao Chen, Fiona K. Middleton, Susanna C. Falcon et al. · Molecular Oncology · 2014 · 26 citations · Full text